标题
Sporadic Late-Onset Nemaline Myopathy: Current Landscape
作者
关键词
-
出版物
Current Neurology and Neuroscience Reports
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-19
DOI
10.1007/s11910-023-01311-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular signatures of inherited and acquired sporadic late onset nemaline myopathies
- (2023) Stefan Nicolau et al. Acta Neuropathologica Communications
- Sporadic late onset nemaline myopathy with concurrent dermatological symptoms responding to immunosuppressive treatment
- (2023) Anirban Nandy et al. BMC Neurology
- Daratumumab for treatment‐refractory antibody‐mediated diseases in neurology
- (2022) Franziska Scheibe et al. EUROPEAN JOURNAL OF NEUROLOGY
- Proteomic profiling of sporadic late‐onset nemaline myopathy
- (2022) Elie Naddaf et al. Annals of Clinical and Translational Neurology
- Coexisting sporadic late onset nemaline myopathy and AL amyloid myopathy – incidental or related?
- (2022) Orly Moshe-Lilie et al. NEUROMUSCULAR DISORDERS
- 68-year old man with progressive weakness and ventilator dependent respiratory failure: a case report of sporadic late onset nemaline myopathy
- (2022) Pradhab Kirupaharan et al. BMC Pulmonary Medicine
- Clinicopathologic Profiles of Sporadic Late-Onset Nemaline Myopathy
- (2022) Bing Zhao et al. Neurology-Neuroimmunology & Neuroinflammation
- Chemotherapy‐based approach is the preferred treatment for sporadic late‐onset nemaline myopathy with a monoclonal protein
- (2021) Rouslan Kotchetkov et al. INTERNATIONAL JOURNAL OF CANCER
- Reply to: Comments on: Chemotherapy‐based approach is the preferred treatment for sporadic late‐onset nemaline myopathy with a monoclonal protein
- (2021) Rouslan Kotchetkov et al. INTERNATIONAL JOURNAL OF CANCER
- Comments on: Chemotherapy‐based approach is the preferred treatment for sporadic late‐onset nemaline myopathy with a monoclonal protein
- (2021) Elie Naddaf et al. INTERNATIONAL JOURNAL OF CANCER
- High prevalence of sporadic late-onset nemaline myopathy in a cohort of whole-exome sequencing negative myopathy patients
- (2021) Willem De Ridder et al. NEUROMUSCULAR DISORDERS
- Impact of hematologic complete response in the treatment of sporadic late‐onset nemaline myopathy associated with monoclonal gammopathy
- (2021) Tânia Maia et al. Clinical Case Reports
- Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance: Report of four patients
- (2020) Ali Asghar Okhovat et al. NEUROMUSCULAR DISORDERS
- Dropped Head in Sporadic Late-onset Nemaline Myopathy
- (2019) Keigo Nakamura et al. INTERNAL MEDICINE
- Nemaline myopathies: a current view
- (2019) Caroline A. Sewry et al. JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
- Sporadic late-onset nemaline myopathy
- (2019) Elie Naddaf et al. NEUROLOGY
- Camptocormia as the presenting symptom in sporadic late onset nemaline myopathy: a case report
- (2019) Matthias Türk et al. BMC MUSCULOSKELETAL DISORDERS
- Myopathies presenting with head drop: Clinical spectrum and treatment outcomes
- (2019) Reem M. Alhammad et al. NEUROMUSCULAR DISORDERS
- Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort
- (2018) Mauro Monforte et al. JOURNAL OF NEUROLOGY
- Sporadic late-onset nemaline myopathy with monoclonal gammopathy of undetermined significance (SLONM-MGUS): An alternative treatment using cyclophosphamide-thalidomide-dexamethasone (CTD) regimen
- (2018) Theerawat Kumutpongpanich et al. NEUROMUSCULAR DISORDERS
- Clinical, histological and radiological responses to methylprednisolone in HIV-associated rod myopathy
- (2017) André M.S. Silva et al. NEUROMUSCULAR DISORDERS
- Monoclonal gammopathy with both nemaline myopathy and amyloid myopathy
- (2017) Min Wang et al. NEUROMUSCULAR DISORDERS
- Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases
- (2017) Lukas J. Schnitzler et al. Orphanet Journal of Rare Diseases
- Autologous stem cell transplantation in a patient with sporadic late-onset nemaline myopathy and monoclonal gammopathy: First Moroccan experience
- (2017) Mohamed Reda Belkhribchia et al. PRESSE MEDICALE
- Adult-onset Nemaline Myopathy Coexisting With Myasthenia Gravis
- (2016) Lingling Cao et al. MEDICINE
- Sporadic late-onset nemaline myopathy as a rare cause of slowly progressive muscle weakness with young adult onset
- (2015) Meiko Hashimoto Maeda et al. MUSCLE & NERVE
- Sporadic late-onset nemaline myopathy in a woman with multiple myeloma successfully treated with lenalidomide/dexamethasone
- (2015) Federica Montagnese et al. MUSCLE & NERVE
- Sporadic late-onset nemaline myopathy with MGUS: Long-term follow-up after melphalan and SCT
- (2014) N. C. Voermans et al. NEUROLOGY
- Sporadic late-onset nemaline myopathy in a patient with systemic lupus erythematosus
- (2013) Dalia Dimitri et al. JOURNAL OF NEUROLOGY
- Sporadic late onset nemaline myopathy and immunoglobulin deposition disease
- (2013) Kathrin Doppler et al. MUSCLE & NERVE
- Isolated camptocormia revealing sporadic late onset nemaline myopathy
- (2013) Fernando Kemta Lekpa et al. PRESSE MEDICALE
- Progressive external ophthalmoplegia as initial manifestation of sporadic late-onset nemaline myopathy
- (2010) Oliver Wengert et al. JOURNAL OF NEUROLOGY
- Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy
- (2009) Jan Novy et al. MUSCLE & NERVE
- Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy
- (2009) Margherita Milone et al. MUSCLE & NERVE
- SPORADIC LATE-ONSET NEMALINE MYOPATHY EFFECTIVELY TREATED BY MELPHALAN AND STEM CELL TRANSPLANT
- (2008) N. C. Voermans et al. NEUROLOGY
- STEM CELL TRANSPLANTATION IN A PATIENT WITH LATE-ONSET NEMALINE MYOPATHY AND GAMMOPATHY
- (2008) O. Benveniste et al. NEUROLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started